Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $17.14 billion. The enterprise value is $17.00 billion.
| Market Cap | 17.14B |
| Enterprise Value | 17.00B |
Important Dates
The next confirmed earnings date is Monday, February 9, 2026, after market close.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 28.17 million shares outstanding. The number of shares has decreased by -5.48% in one year.
| Current Share Class | 28.17M |
| Shares Outstanding | 28.17M |
| Shares Change (YoY) | -5.48% |
| Shares Change (QoQ) | -1.12% |
| Owned by Insiders (%) | 19.54% |
| Owned by Institutions (%) | 86.65% |
| Float | 22.65M |
Valuation Ratios
The trailing PE ratio is 42.49 and the forward PE ratio is 37.01. MEDP's PEG ratio is 2.65.
| PE Ratio | 42.49 |
| Forward PE | 37.01 |
| PS Ratio | 7.61 |
| Forward PS | 6.05 |
| PB Ratio | 59.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 25.32 |
| P/OCF Ratio | 24.10 |
| PEG Ratio | 2.65 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.74, with an EV/FCF ratio of 25.11.
| EV / Earnings | 39.26 |
| EV / Sales | 7.21 |
| EV / EBITDA | 31.74 |
| EV / EBIT | 33.52 |
| EV / FCF | 25.11 |
Financial Position
The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.49.
| Current Ratio | 0.57 |
| Quick Ratio | 0.51 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.21 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 73.70% and return on invested capital (ROIC) is 43.09%.
| Return on Equity (ROE) | 73.70% |
| Return on Assets (ROA) | 16.52% |
| Return on Invested Capital (ROIC) | 43.09% |
| Return on Capital Employed (ROCE) | 108.09% |
| Revenue Per Employee | $399,724 |
| Profits Per Employee | $73,377 |
| Employee Count | 5,900 |
| Asset Turnover | 1.23 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $86.42 million in taxes.
| Income Tax | 86.42M |
| Effective Tax Rate | 16.64% |
Stock Price Statistics
The stock price has increased by +73.41% in the last 52 weeks. The beta is 1.43, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | +73.41% |
| 50-Day Moving Average | 581.95 |
| 200-Day Moving Average | 441.43 |
| Relative Strength Index (RSI) | 63.69 |
| Average Volume (20 Days) | 211,832 |
Short Selling Information
The latest short interest is 1.44 million, so 5.10% of the outstanding shares have been sold short.
| Short Interest | 1.44M |
| Short Previous Month | 1.37M |
| Short % of Shares Out | 5.10% |
| Short % of Float | 6.34% |
| Short Ratio (days to cover) | 5.24 |
Income Statement
In the last 12 months, MEDP had revenue of $2.36 billion and earned $432.92 million in profits. Earnings per share was $14.32.
| Revenue | 2.36B |
| Gross Profit | 1.64B |
| Operating Income | 507.04M |
| Pretax Income | 519.43M |
| Net Income | 432.92M |
| EBITDA | 535.54M |
| EBIT | 507.04M |
| Earnings Per Share (EPS) | $14.32 |
Balance Sheet
The company has $285.35 million in cash and $143.97 million in debt, with a net cash position of $141.38 million or $5.02 per share.
| Cash & Cash Equivalents | 285.35M |
| Total Debt | 143.97M |
| Net Cash | 141.38M |
| Net Cash Per Share | $5.02 |
| Equity (Book Value) | 293.64M |
| Book Value Per Share | 10.27 |
| Working Capital | -546.63M |
Cash Flow
In the last 12 months, operating cash flow was $711.24 million and capital expenditures -$34.46 million, giving a free cash flow of $676.77 million.
| Operating Cash Flow | 711.24M |
| Capital Expenditures | -34.46M |
| Free Cash Flow | 676.77M |
| FCF Per Share | $24.03 |
Margins
Gross margin is 69.58%, with operating and profit margins of 21.50% and 18.36%.
| Gross Margin | 69.58% |
| Operating Margin | 21.50% |
| Pretax Margin | 22.02% |
| Profit Margin | 18.36% |
| EBITDA Margin | 22.71% |
| EBIT Margin | 21.50% |
| FCF Margin | 28.70% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.48% |
| Shareholder Yield | 5.48% |
| Earnings Yield | 2.53% |
| FCF Yield | 3.95% |
Analyst Forecast
The average price target for MEDP is $479.64, which is -21.17% lower than the current price. The consensus rating is "Hold".
| Price Target | $479.64 |
| Price Target Difference | -21.17% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 12.23% |
| EPS Growth Forecast (5Y) | 12.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 5.76 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.76 |
| Piotroski F-Score | 6 |